Bharat Biotech mulls IPO to raise over $500 million
Bharat Biotech mulls IPO to raise over $500 million is drawing significant interest across the industry.
Bharat Biotech mulls IPO to raise over $500 million - New Delhi, March 1 The developer of Covid-19 vaccine Covaxin, Bharat Biotech is considering an initial public offering ... Get Latest News on Business only on lokmattimes.com
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Vaishnaw tours semicon and chip firms in Bengaluru
- Ex UK PM Sunak to Address Curtain Raiser to India AI Impact Summit 2026
- The Canadian AI Stock That Could Soon Go Public
- EastEnders airs worrying Ravi scenes as dark twist in storyline looms
Source: Original →